Adams Brian's Insider Trades & SAST Disclosures
Adams Brian's most recent trade in Relay Therapeutics Inc was a trade of 139,141 Common Stock done . Disclosure was reported to the exchange on Jan. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adams Brian.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 139,141 | 427,061 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 28 Jan 2025 | 33,688 | 287,920 | - | 4.6 | 155,975 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 28 Jan 2025 | 20,791 | 406,270 | - | 4.4 | 91,896 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 27 Dec 2024 | 299 | 321,608 | - | 4.4 | 1,310 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 28 Oct 2024 | 1,632 | 321,907 | - | 6.1 | 9,890 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 27 Sep 2024 | 295 | 323,539 | - | 7.5 | 2,215 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 29 Jul 2024 | 1,638 | 323,834 | - | 8.8 | 14,496 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 27 Jun 2024 | 295 | 325,472 | - | 6.3 | 1,847 | Common Stock |
| Relay Therapeutics Inc | Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.38 per share. | 29 Apr 2024 | 1,623 | 325,767 | - | 6.4 | 10,355 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.70 per share. | 27 Mar 2024 | 348 | 327,390 | - | 7.7 | 2,680 | Common Stock |
| Relay Therapeutics Inc | Adams Brian | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 29 Jan 2024 | 1,929 | 327,738 | - | 9.6 | 18,596 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 200,000 | 329,667 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 27 Dec 2023 | 294 | 129,667 | - | 11.5 | 3,384 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.80 per share. | 28 Jul 2023 | 1,628 | 131,887 | - | 11.8 | 19,210 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 28 Jun 2023 | 42,153 | 500,250 (2%) | 0% | 3.1 | 131,096 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2023 | 42,153 | 0 | - | - | Employee Stock Option (right to buy) | |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. | 28 Jun 2023 | 25,647 | 474,603 (2%) | 0% | 7.7 | 197,225 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 27 Jun 2023 | 294 | 133,515 | - | 12.1 | 3,563 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.16 per share. | 28 Apr 2023 | 1,936 | 133,809 | - | 11.2 | 21,606 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2023 | 55,556 | 458,097 (2%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 27 Mar 2023 | 347 | 135,745 | - | 15.4 | 5,330 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.56 per share. | 30 Jan 2023 | 864 | 136,092 | - | 21.6 | 18,628 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 97,630 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 85,425 | 136,956 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 73,220 | 73,220 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 12 Jan 2023 | 9,994 | 51,531 | - | 20 | 199,880 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.02 per share. | 11 Jan 2023 | 2,409 | 402,541 (1%) | 0% | 5.0 | 12,093 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 11 Jan 2023 | 1,886 | 404,950 (1%) | 0% | 5.0 | 9,336 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 01 Jan 2023 | 18,292 | 406,836 (1%) | 0% | 4.9 | 90,545 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 01 Jan 2023 | 3,560 | 425,128 (1%) | 0% | 5.0 | 17,622 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 27 Dec 2022 | 295 | 61,525 | - | 14.5 | 4,275 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 28 Oct 2022 | 728 | 61,820 | - | 21.5 | 15,681 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.73 per share. | 27 Sep 2022 | 294 | 62,548 | - | 22.7 | 6,683 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | CO-PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 200,000 | 428,688 (1%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.27 per share. | 28 Jul 2022 | 734 | 62,842 | - | 21.3 | 15,612 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 20.31 per share. | 27 Jun 2022 | 300 | 63,576 | - | 20.3 | 6,093 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.57 per share. | 28 Apr 2022 | 708 | 63,876 | - | 25.6 | 18,104 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 29.87 per share. | 29 Mar 2022 | 333 | 64,584 | - | 29.9 | 9,947 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 78,540 | 78,540 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 39,270 | 64,917 | - | 0 | Common Stock | |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.86 per share. | 14 Jan 2022 | 2,523 | 228,688 (1%) | 0% | 14.9 | 37,492 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.68 per share. | 12 Jan 2022 | 1,958 | 231,211 (1%) | 0% | 15.7 | 30,701 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 03 Jan 2022 | 3,418 | 235,833 (1%) | 0% | 15.7 | 53,560 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.54 per share. | 03 Jan 2022 | 2,664 | 233,169 (1%) | 0% | 15.5 | 41,399 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 27 Dec 2021 | 295 | 24,989 | - | 33.1 | 9,765 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 35.42 per share. | 15 Nov 2021 | 6,500 | 25,284 | - | 35.4 | 230,230 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 6,500 | 140,786 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 15 Nov 2021 | 6,500 | 31,784 | - | 4.1 | 26,780 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 36.87 per share. | 27 Sep 2021 | 293 | 25,284 | - | 36.9 | 10,803 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 13 Sep 2021 | 6,500 | 32,077 | - | 4.1 | 26,780 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 6,500 | 147,286 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 35.02 per share. | 13 Sep 2021 | 6,500 | 25,577 | - | 35.0 | 227,630 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 35.81 per share. | 28 Jun 2021 | 293 | 25,577 | - | 35.8 | 10,492 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 07 Jun 2021 | 6,500 | 32,370 | - | 4.1 | 26,780 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 6,500 | 153,786 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 07 Jun 2021 | 6,500 | 25,870 | - | 35 | 227,500 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 6,500 | 160,286 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 26 Apr 2021 | 6,500 | 32,370 | - | 4.1 | 26,780 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 26 Apr 2021 | 6,500 | 25,870 | - | 35 | 227,500 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 31,740 | 31,740 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 15,870 | 25,870 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Sale of securities on an exchange or to another person at price $ 55.05 per share. | 28 Jan 2021 | 5,000 | 10,000 | - | 55.1 | 275,250 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 5,000 | 166,786 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 28 Jan 2021 | 5,000 | 15,000 | - | 4.1 | 20,600 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.35 per share. | 12 Jan 2021 | 1,809 | 211,126 (0%) | 0% | 46.3 | 83,847 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.69 per share. | 04 Jan 2021 | 3,341 | 215,754 (0%) | 0% | 41.7 | 139,286 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.83 per share. | 04 Jan 2021 | 2,819 | 212,935 (0%) | 0% | 41.8 | 117,919 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 67,588 | 67,588 | - | - | Stock Option (Right to Buy) | |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 496 | 219,095 (0%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Brian Adams | General Counsel | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 20 Jul 2020 | 10,000 | 10,000 | - | 20 | 200,000 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.08 per share. | 05 Jun 2020 | 3,000 | 218,599 (0%) | 0% | 60.1 | 180,240 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 05 Jun 2020 | 3,000 | 221,599 (0%) | 0% | 3.1 | 9,330 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2020 | 3,000 | 54,153 | - | - | Employee Stock Option (right to buy) | |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2020 | 3,000 | 57,153 | - | - | Employee Stock Option (right to buy) | |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 01 May 2020 | 3,000 | 221,599 (0%) | 0% | 3.1 | 9,330 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.23 per share. | 01 May 2020 | 2,800 | 218,799 (0%) | 0% | 60.2 | 168,644 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.21 per share. | 01 May 2020 | 200 | 218,599 (0%) | 0% | 61.2 | 12,242 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.18 per share. | 20 Apr 2020 | 9,559 | 218,599 (0%) | 0% | 60.2 | 575,261 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 20 Apr 2020 | 9,559 | 228,158 (1%) | 0% | 3.1 | 29,728 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2020 | 9,559 | 60,153 | - | - | Employee Stock Option (right to buy) | |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2020 | 2,441 | 69,712 | - | - | Employee Stock Option (right to buy) | |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.09 per share. | 15 Apr 2020 | 2,441 | 218,599 (0%) | 0% | 60.1 | 146,680 | Common Stock |
| Tabula Rasa HealthCare Inc | Brian W Adams | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 15 Apr 2020 | 2,441 | 221,040 (0%) | 0% | 3.1 | 7,592 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges